Tumor-driven stromal reprogramming in the pre-metastatic lymph node

Michelle Piquet1, David A Ruddy1, Viviana Cremasco2

  • 1Oncology Innovative Targets and Technologies, Novartis, Cambridge, MA, 02139, USA.

F1000Research
|October 27, 2025
PubMed
Summary

Tumor signals reprogram lymph node stromal cells, creating a pre-metastatic niche. These changes, involving marginal reticular cells and lymphatic endothelial cells, facilitate cancer cell metastasis.